EU approves LEO Pharma’s psoriasis biologic
admin 20th July 2017 Uncategorised 0A new treatment option has been approved in the European Union for patients with psoriasis, paving the way for access to a novel approach for those with moderate-to-severe forms of the disease who are candidates for systemic therapy.
More: EU approves LEO Pharma’s psoriasis biologic
Source: News